PAVmed stock: buy or sell?
May 22nd, 2020
PAVmed Inc. operates as a medical device company in the United States. Its product pipeline includes PortIO, a long-term implantable vascular access device; CarpX, a percutaneous device to treat carpal tunnel syndrome; NextCath, a self-anchoring catheter; DisappEAR: Antibiotic-eluting resorbable ear tube; NextFlo, a disposable infusion pump; and Caldus, a disposable tissue ablation device.
Should I buy PAVmed stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Having a trading plan helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with PAVmed stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is PAVmed stock a buy?
Banks and financial institutions publish stock ratings everyday.Unfortunately, we couldn't find any rating for PAVM stock for the last 30 days.
PAVmed stock analysis
After climbing for 4 days, Friday PAVmed collapsed a frightening -11.70%, closing at $2.34.
After climbing for 4 sessions, Friday PAVmed collapsed a frightening -11.70%, closing at $2.34. On February, SMA100d and SMA200d crossed up triggering a rise of 28.57%. From a daily perspective, PAVM is in a short term uptrend after plotting its last bottom ($2.03, on May/13) higher than the previous bottom, and its last top ($2.82, on Thursday) also over the previous top. Now trading in between its last bottom and last top PAVM might consolidate in a plain range, waiting to break out over $2.82 or down under $2.03. On March PAVM price bounced up over the SMA of 100 days demonstrating to be a significant support for this stock.
PAVmed rose a great 3.08% this week. Late April PAVM plummed a hair-raising -21.08% in just one week. Early May PAVM boosted a dazzling 12.07% in just one week.
PAVmed is in a glaring downtrend, marking consecutive declining peaks and bottoms. Now is trading in between the - range. There is a chance to rebound and reverse this situation if price can hold above the level. Early February, SMA20w and SMA40w crossed up triggering a rise of 58.11%. Since late December 2019 when PAVM stock price broke up the SMA40w line, it gained $1.34 (134.00%).
PAVmed stock price history
PAVmed IPO was on August 16th, 2016 at $14.00 per share1. Since then, PAVM stock sliced a -83.30%, with a yearly average of -27.80%.
1: Adjusted price after possible price splits or reverse-splits.
PAVmed stock historical price chart
PAVM stock reached 52-week highs on February at $3.45, and all-time highs 2016-09-01 with a price of 14.49.
PAVmed stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last 30 days we have not detected any price prediction for PAVmed stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter presenting its last earnings report , PAVmed . As soon as we get its actual EPS from the earnings report, we will extend this report.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to , last anual revenues report draw of to M USD. When comparing vs , , profit margin (that is, the net income divided by revenues) a to .
Quarterly financial resultsReported quarter income marked $-3.25 M with a profit margin of . Profit margin remained constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, PAVmed sales marked a tight movement and stayed constant a nan%. Looking back to recent quarterly results, PAVmed posted 6 positive quarters in a row.
PAVmed ownershipWhen you are planning to buy a company, it's always worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For PAVmed, 19.64% of all outstanding shares are owned by its staff.
In case of PAVmed stock, 4.76% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for PAVM stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to PAVmed:
|Market cap||$104.4 M|
|Total shares||44.6 M|
|Float shares||31.3 M|
|- Institutional holdings (%)||4.8%|
|- Insider holdings (%)||19.6%|
|Shares in short selling||0.0%|
|Friday, May 22nd, 2020|
|Day range||$2.25 - $2.48|
|Average true range||$0.18|
|50d mov avg||$2.09|
|100d mov avg||$1.98|
|200d mov avg||$1.46|
PAVmed performanceTo better understand PAVmed performance you must compare its gains with other related stocks in same sector or industry. We compared PAVmed against in the following table: